Cero Therapeutics Holdings, Inc.
CEROOTCCIK 1870404HealthcareFiscal year ends Dec 31
Reports and events: 133 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-0712:30 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001213900-26-107410 |
| 2026-08-3120:52 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001213900-26-095776 |
| 2026-08-1420:06 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001213900-26-090030 |
| 2026-07-1720:37 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001213900-26-079207 |
| 2026-06-2620:05 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001213900-26-072602 |
| 2026-05-2920:05 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001213900-26-062802 |
| 2026-05-1520:12 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001213900-26-057753 |
| 2026-05-0120:10 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001213900-26-050951 |
| 2026-04-3020:34 ET | 10-K/A | Annual report, amendedPeriod 2025-12-31 | 0001213900-26-050302 |
| 2026-04-1520:05 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001213900-26-044040 |
| 2026-04-1420:01 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001213900-26-043519 |
| 2026-03-1122:44 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001213900-26-025817 |
| 2026-02-1321:35 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 4.01 Change of auditor; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001213900-26-016474 |
| 2026-02-0414:12 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-011844 |
| 2026-02-0322:15 ET | 8-K | 3.01 Delisting notice | 0001213900-26-011587 |
| 2026-01-0721:37 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-002187 |
| 2025-12-1921:49 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001213900-25-123912 |
| 2025-12-0522:12 ET | S-1 | Registration statement | 0001213900-25-118817 |
| 2025-12-0213:30 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001213900-25-116971 |
| 2025-11-2813:31 ET | DEF 14A | Proxy statementPeriod 2025-12-19 | 0001213900-25-115783 |
| 2025-11-1921:10 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001213900-25-112619 |
| 2025-10-3023:27 ET | 8-K | 3.01 Delisting notice; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-103661 |
| 2025-10-1620:17 ET | 8-K | 1.01 Entry into a material agreement; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-099560 |
| 2025-10-1413:11 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001213900-25-098421 |
| 2025-09-2220:10 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-25-090107 |
| 2025-09-0512:32 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-084737 |
| 2025-09-0420:05 ET | 8-K | 3.01 Delisting notice | 0001213900-25-084498 |
| 2025-08-2220:06 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001213900-25-079898 |
| 2025-07-2120:35 ET | S-1 | Registration statement | 0001213900-25-066152 |
| 2025-07-1820:05 ET | 8-K | 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001213900-25-065655 |
| 2025-07-1412:00 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001213900-25-063475 |
| 2025-07-0812:00 ET | 8-K | 8.01 Other events | 0001213900-25-061911 |
| 2025-06-3021:09 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001213900-25-059738 |
| 2025-06-1712:24 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-054961 |
| 2025-06-1321:14 ET | 8-K | 3.01 Delisting notice | 0001213900-25-054371 |
| 2025-06-1113:20 ET | 8-K | 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-053292 |
| 2025-06-0612:33 ET | 8-K | 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-051750 |
| 2025-06-0220:22 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001213900-25-050055 |
| 2025-05-2921:10 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001213900-25-048998 |
| 2025-05-1520:57 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001213900-25-044335 |
| 2025-05-0820:10 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-041063 |
| 2025-05-0721:48 ET | DEF 14A | Proxy statementPeriod 2025-05-29 | 0001213900-25-040263 |
| 2025-04-2820:10 ET | 10-K/A | Annual report, amendedPeriod 2024-12-31 | 0001213900-25-036075 |
| 2025-04-2520:03 ET | 8-K | 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-25-035535 |
| 2025-04-2212:20 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-033946 |
| 2025-04-1520:30 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001213900-25-032134 |
| 2025-04-0423:17 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001213900-25-029113 |
| 2025-02-1221:10 ET | 8-K | 8.01 Other events | 0001213900-25-012891 |
| 2025-02-0722:21 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001213900-25-011405 |
| 2025-02-0613:22 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-010731 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:16 ET. Listed shows no prices and gives no investment advice.